ReWind Therapeutics
Board
9 directors, 1 in day-to-day management, 1 auditor, no change since August 2026Director
since 27-06-2022
term until 20-05-2027
earlier director, until 13-08-2026
listed in the 2025 annual accounts, filed on 08-07-2026
Director
since 27-06-2022
term until 20-05-2027
earlier director, until 13-08-2026
listed in the 2025 annual accounts, filed on 08-07-2026
Director
current term since 27-06-2022
term until 20-05-2027
listed in the 2025 annual accounts, filed on 08-07-2026
Andersson Claus Asbjorn
Director
since 27-01-2023
term until 26-01-2029
listed in the 2025 annual accounts, filed on 08-07-2026
Director
since 08-05-2024
term until 16-05-2030
earlier director, until 13-08-2026
listed in the 2025 annual accounts, filed on 08-07-2026
BIOSKILLS BV
Independent director and day-to-day manager, permanent representative VAN heusden Jimmy Arnold Viviane
independent director since 16-05-2024
day-to-day manager appointed by deed of 13-03-2026
term until 16-05-2030
listed in the 2025 annual accounts, filed on 08-07-2026
Director, permanent representative WILMS Tobias Sebastiaan
since 16-05-2024
term until 16-05-2030
also on the board of 74 other companies
listed in the 2025 annual accounts, filed on 08-07-2026
5 other companies bankrupt, 1 judicially dissolvedDirector
since 17-03-2025
earlier director, until 13-08-2026
listed in the 2025 annual accounts, filed on 08-07-2026
Statutory auditor, permanent representative Didier Delanoye
since 08-05-2024
3-year term from 2024
listed in the 2025 annual accounts, filed on 08-07-2026
- BIOSKILLS
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 11-07-2019
Permanent representatives 2
VAN heusden Jimmy Arnold Viviane
Permanent representative, for BIOSKILLS
appointed by deed of 13-08-2026
WILMS Tobias Sebastiaan
Permanent representative, for PARTICIPATIEMAATSCHAPPIJ VLAANDEREN
appointed by deed of 13-08-2026
Mandates through the years
25 names, the dashed line is todayLOHMER Stefan
Director
Director
Stefaan Allemeersch
Director
Director
BIOSKILLS
Independent director, Day-to-day manager
Independent director, Day-to-day manager
Andersson Claus Asbjorn
Director
Director
BAUKE Anninga
Director
Director
Dr Paul Nicklin
Director
Director
NICKLIN Paul Leslie
Director
Director
BV PwC Bedrijfsrevisoren
Statutory auditor
Statutory auditor
ANDERSSON Claus Asbjørn
Director
Director
Cornelis Been
Independent director
Independent director
Anhabio Consulting GmbH
Day-to-day manager
Day-to-day manager
Dr. Sebastian Kreuz
Director
Director
Baker Tilly Bedrijfsrevisoren CVBA
Statutory auditor
Statutory auditor
Cheryl Zimberlin
Director
Director
BV Baker Tilly Belgium Bedrijfsrevisoren
Statutory auditor
Statutory auditor
lan Reynolds
Day-to-day manager
Day-to-day manager
David Devigne
Director
Director
Dr.KASUBOSKI James
Director
Director
KOSTKA Marcus
Director
Director
lan J.Reynolds
Day-to-day manager
Day-to-day manager
TOLIA Alexandra
Director
Director
Alessandro SIDOLI
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- ALLEMEERSCH Stefaan Eddy Madeleine
- Director, from 29-09-2017 to date
- Director, until 13-08-2026
- LOHMER Stefan
- Director, from 29-09-2017 to 13-08-2026
- Director, appointed by deed of 13-08-2026, still in office
- Stefaan Allemeersch
- Director, from 29-09-2017 to date
- BIOSKILLS
- Independent director, appointed by deed of 27-04-2018, still in office
- Day-to-day manager, appointed by deed of 13-03-2026, still in office
- PARTICIPATIEMAATSCHAPPIJ VLAANDEREN
- Director, appointed by deed of 06-10-2020, until 13-08-2026
- Director, appointed by deed of 13-08-2026, still in office
- Andersson Claus Asbjorn
- Director, since before 31-12-2022
- BAUKE Anninga
- Director, appointed by deed of 03-01-2024, until 13-08-2026
- Director, appointed by deed of 13-08-2026, still in office
- Dr Paul Nicklin
- Director, since before 31-12-2024
- NICKLIN Paul Leslie
- Director, since before 31-12-2024
- Director, until 13-08-2026
- BV PwC Bedrijfsrevisoren
- Statutory auditor, from 08-05-2024 to date
- ANDERSSON Claus Asbjørn
- Director, appointed by deed of 09-02-2023, until 13-08-2026
- Cornelis Been
- Independent director, appointed by deed of 06-10-2020, until 13-08-2026
- Anhabio Consulting GmbH
- Day-to-day manager, appointed by deed of 04-10-2021, until 13-03-2026
- Dr. Sebastian Kreuz
- Director, appointed by deed of 05-12-2019, until 13-03-2025
- Baker Tilly Bedrijfsrevisoren CVBA
- Statutory auditor, from 10-06-2021 to 29-08-2024
- Cheryl Zimberlin
- Director, appointed by deed of 26-03-2019, until 07-12-2023
- BV Baker Tilly Belgium Bedrijfsrevisoren
- Statutory auditor, appointed by deed of 05-01-2018, until 30-07-2021
- lan Reynolds
- Day-to-day manager, until 21-09-2020
- David Devigne
- Director, appointed by deed of 26-03-2019, until 31-03-2020
- Dr.KASUBOSKI James
- Director, appointed by deed of 10-07-2019, until 23-09-2019
- Board, from before 11-07-2019, no longer listed in the 2025 annual accounts
- KOSTKA Marcus
- Director, appointed by deed of 05-01-2018, until 11-06-2019
- Alicia Jacqueline Mercédès IRURZUN-LAFITTE
- Director, appointed by deed of 05-01-2018, until 26-03-2019
- lan J.Reynolds
- Day-to-day manager, appointed by deed of 26-03-2019, last mentioned in 2019
- TOLIA Alexandra
- Director, appointed by deed of 05-01-2018, until 26-03-2019
- Alessandro SIDOLI
- Director, appointed by deed of 17-10-2017, until 05-01-2018
Control
Shareholder
Equity €24.5m
Loss €4.8m in 2025 (loss €1.6m in 2024)
Checked score 88
16.12%
This company
ReWind Therapeutics
Equity -€2.6m
Loss €4.6m in 2025
Capital
- Capital
- €8,213,684.93
- Shares
- 787,747 in the deed of 13-08-2026 and 1 later capital increase
- Contribution per share
- €10.43
- Equity per share
- -€3.30 in 2025
- Source
- deed of 13-08-2026
Owners through the years
as the annual accounts name themOwners as a list
- BIOTECH FONDS VLAANDEREN
- Participatiemaatschappij Vlaanderen
Source: lists of holdings in the owners' accounts
Articles of association
deed of 13-08-2026 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At most 7 directorsTerm of at most 6 years
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of May at 15:00
Shareholders
2 ownersOwners 2
- Equity €24.5m Loss of €4.8m in 2025 (loss of €1.6m in 2024) Checked score 8816.12%
- Equity €4.18bn Profit of €17.2m in 2025 (profit of €27.2m in 2024)5.37%
Capital transactions
Shareholders according to the deeds
At incorporation
deed of 17-10-2017 ↗
- AXXAM S.P.A. 14,750 shares (59%) · €1,020,700
- KATHOLIEKE UNIVERSITEIT LEUVEN (BE 0419.052.173) 10,250 shares (41%) · €709,300
Capital over time
- 13-08-2026 Capital increase of €5,458,649.76 · to €8,213,684.93 · 105,481 new shares · “inbreng zekere,vaststaande en opeisbare schuldvordering ten laste van Vennootschap”
- 13-08-2026 Capital increase of €3,999,937.48 · to €12,213,622.41 · 206,822 new shares at €19.34 per share, 30.3% of the 682,266 shares after the increase
- 10-03-2025 Capital increase of €10,805,033.17 · to €27,755,029.17 · 156,595 new shares, 44.5% of the 352,241 shares after the increase · in kind
- 10-03-2025 Capital reduction of €25,000,000 · to €2,755,029.17
- 10-03-2025 Capital increase of €6 · to €2,755,035.17 · 17,722 new shares, 4.8% of the 369,963 shares after the increase · in cash
- 06-01-2022 Capital increase of €3,196,172 · to €16,949,996 · 34,741 new shares at €92 per share · in cash
- 11-07-2019 Capital increase of €8,827,584 · to €13,753,824 · 95,952 new shares at €92 per share, 59.6% of the 160,905 shares after the increase · in cash
- 05-01-2018 Capital increase of €3,196,240 · to €4,926,240 · 39,953 new shares at €80 per share, 61.5% of the 64,953 shares after the increase · in cash
Show 1 older capital entries
- 17-10-2017 Incorporation · €1,730,000 · 25,000 shares
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off5 other companies of this director went bankrupt (2022, 2023, 2025, 2026) and 1 was judicially dissolved (2025).
- QOLLABI bankruptcy on 07-05-2026Official Gazetteappointed in 2022, still in office
- REIN4CED bankruptcy on 29-12-2025Official Gazetteappointed in 2022, still in office
- OXYPOINT bankruptcy on 11-12-2025Official Gazettemandate 2020 to 2022
- OTRA SOLUTIONS judicial dissolution on 20-11-2025Official Gazetteappointed in 2021, still in office
- VILOC bankruptcy on 26-01-2023Official Gazettemandate until 2022
- LindaCare bankruptcy on 02-06-2022Official Gazetteappointed in 2018, still in office
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.